Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930293 · ClinicalTrials.gov registry record · NA
Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00930293 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants.
The verdict
NCT00930293, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will examine the feasibility and efficacy of a personalized psychotherapy treatment for people with depression and co-occurring anxiety.
Interventions
- BEHAVIORAL Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS)
- BEHAVIORAL Brief Supportive Psychotherapy (BSP)
- DRUG Citalopram hydrobromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930293
The ClinicalTrials.gov registry entry for NCT00930293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS) is the first listed.
NCT00930293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930293 about?
NCT00930293 is a clinical study titled "Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety". This study will examine the feasibility and efficacy of a personalized psychotherapy treatment for people with depression and co-occurring anxiety.
What is the current status of trial NCT00930293?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00930293?
The interventions under investigation include: Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS) (BEHAVIORAL), Brief Supportive Psychotherapy (BSP) (BEHAVIORAL), Citalopram hydrobromide (DRUG).
Who is sponsoring clinical trial NCT00930293?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.